BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luo X, Li M, Zhan K, Yang W, Zhang L, Wang K, Yu P, Zhang L. Selective inhibition of TRPM2 channel by two novel synthesized ADPR analogues. Chem Biol Drug Des 2018;91:552-66. [PMID: 29034580 DOI: 10.1111/cbdd.13119] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
Number Citing Articles
1 Luo X, Li M, Zhan K, Yang W, Zhang L, Wang K, Yu P, Zhang L. Selective inhibition of TRPM2 channel by two novel synthesized ADPR analogues. Chem Biol Drug Des 2018;91:552-66. [PMID: 29034580 DOI: 10.1111/cbdd.13119] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
2 Fourgeaud L, Dvorak C, Faouzi M, Starkus J, Sahdeo S, Wang Q, Lord B, Coate H, Taylor N, He Y, Qin N, Wickenden A, Carruthers N, Lovenberg TW, Penner R, Bhattacharya A. Pharmacology of JNJ-28583113: A novel TRPM2 antagonist. Eur J Pharmacol 2019;853:299-307. [PMID: 30965058 DOI: 10.1016/j.ejphar.2019.03.043] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
3 Kouhpayeh S, Shariati L, Boshtam M, Rahimmanesh I, Mirian M, Esmaeili Y, Najaflu M, Khanahmad N, Zeinalian M, Trovato M, Tay FR, Khanahmad H, Makvandi P. The Molecular Basis of COVID-19 Pathogenesis, Conventional and Nanomedicine Therapy. Int J Mol Sci 2021;22:5438. [PMID: 34064039 DOI: 10.3390/ijms22115438] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Baszczyňski O, Watt JM, Rozewitz MD, Fliegert R, Guse AH, Potter BVL. Synthesis of phosphonoacetate analogues of the second messenger adenosine 5'-diphosphate ribose (ADPR). RSC Adv 2020;10:1776-85. [PMID: 31934327 DOI: 10.1039/C9RA09284F] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Wang Q, Liu N, Ni YS, Yang JM, Ma L, Lan XB, Wu J, Niu JG, Yu JQ. TRPM2 in ischemic stroke: Structure, molecular mechanisms, and drug intervention. Channels (Austin) 2021;15:136-54. [PMID: 33455532 DOI: 10.1080/19336950.2020.1870088] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Kamei J, Aizawa N, Nakagawa T, Kaneko S, Fujimura T, Homma Y, Kume H, Igawa Y. Lacking transient receptor potential melastatin 2 attenuates lipopolysaccharide-induced bladder inflammation and its associated hypersensitivity in mice. Int J Urol 2021;28:107-14. [PMID: 33026125 DOI: 10.1111/iju.14389] [Reference Citation Analysis]
7 Kühn FJP. Structure-Function Relationship of TRPM2: Recent Advances, Contradictions, and Open Questions. Int J Mol Sci 2020;21:E6481. [PMID: 32899872 DOI: 10.3390/ijms21186481] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
8 Belrose JC, Jackson MF. TRPM2: a candidate therapeutic target for treating neurological diseases. Acta Pharmacol Sin 2018;39:722-32. [PMID: 29671419 DOI: 10.1038/aps.2018.31] [Cited by in Crossref: 55] [Cited by in F6Publishing: 45] [Article Influence: 13.8] [Reference Citation Analysis]
9 Pan T, Zhu QJ, Xu LX, Ding X, Li JQ, Sun B, Hua J, Feng X. Knocking down TRPM2 expression reduces cell injury and NLRP3 inflammasome activation in PC12 cells subjected to oxygen-glucose deprivation. Neural Regen Res 2020;15:2154-61. [PMID: 32394974 DOI: 10.4103/1673-5374.282271] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Zhang H, Yu P, Lin H, Jin Z, Zhao S, Zhang Y, Xu Q, Jin H, Liu Z, Yang W, Zhang L. The Discovery of Novel ACA Derivatives as Specific TRPM2 Inhibitors that Reduce Ischemic Injury Both In Vitro and In Vivo. J Med Chem 2021;64:3976-96. [PMID: 33784097 DOI: 10.1021/acs.jmedchem.0c02129] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Ji D, Luo ZW, Ovcjak A, Alanazi R, Bao MH, Feng ZP, Sun HS. Role of TRPM2 in brain tumours and potential as a drug target. Acta Pharmacol Sin 2022;43:759-70. [PMID: 34108651 DOI: 10.1038/s41401-021-00679-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
12 Jimenez I, Prado Y, Marchant F, Otero C, Eltit F, Cabello-Verrugio C, Cerda O, Simon F. TRPM Channels in Human Diseases. Cells 2020;9:E2604. [PMID: 33291725 DOI: 10.3390/cells9122604] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Alemán OR, Mora N, Rosales C. The Antibody Receptor Fc Gamma Receptor IIIb Induces Calcium Entry via Transient Receptor Potential Melastatin 2 in Human Neutrophils. Front Immunol 2021;12:657393. [PMID: 34054821 DOI: 10.3389/fimmu.2021.657393] [Reference Citation Analysis]
14 Zhang H, Zhao S, Yu J, Yang W, Liu Z, Zhang L. Medicinal chemistry perspective of TRPM2 channel inhibitors: where we are and where we might be heading? Drug Discov Today 2020;25:2326-34. [PMID: 33065292 DOI: 10.1016/j.drudis.2020.09.039] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
15 Wong KK, Banham AH, Yaacob NS, Nur Husna SM. The oncogenic roles of TRPM ion channels in cancer. J Cell Physiol. 2019;. [PMID: 30710353 DOI: 10.1002/jcp.28168] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
16 Zhang H, Liu H, Luo X, Wang Y, Liu Y, Jin H, Liu Z, Yang W, Yu P, Zhang L, Zhang L. Design, synthesis and biological activities of 2,3-dihydroquinazolin-4(1H)-one derivatives as TRPM2 inhibitors. Eur J Med Chem 2018;152:235-52. [PMID: 29723786 DOI: 10.1016/j.ejmech.2018.04.045] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
17 Hu H, Zhu T, Gong L, Zhao Y, Shao Y, Li S, Sun Z, Ling Y, Tao Y, Ying Y, Lan C, Xie Y, Jiang P. Transient receptor potential melastatin 2 contributes to neuroinflammation and negatively regulates cognitive outcomes in a pilocarpine-induced mouse model of epilepsy. Int Immunopharmacol 2020;87:106824. [PMID: 32731181 DOI: 10.1016/j.intimp.2020.106824] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
18 Malko P, Jiang LH. TRPM2 channel-mediated cell death: An important mechanism linking oxidative stress-inducing pathological factors to associated pathological conditions. Redox Biol 2020;37:101755. [PMID: 33130440 DOI: 10.1016/j.redox.2020.101755] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
19 Tóth B, Iordanov I, Csanády L. Selective profiling of N- and C-terminal nucleotide-binding sites in a TRPM2 channel. J Gen Physiol 2020;152:e201912533. [PMID: 32211872 DOI: 10.1085/jgp.201912533] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
20 Zielińska W, Zabrzyński J, Gagat M, Grzanka A. The Role of TRPM2 in Endothelial Function and Dysfunction. Int J Mol Sci 2021;22:7635. [PMID: 34299254 DOI: 10.3390/ijms22147635] [Reference Citation Analysis]
21 Kühn FJP, Watt JM, Potter BVL, Lückhoff A. Different substrate specificities of the two ADPR binding sites in TRPM2 channels of Nematostella vectensis and the role of IDPR. Sci Rep 2019;9:4985. [PMID: 30899048 DOI: 10.1038/s41598-019-41531-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
22 Jiang LH, Li X, Syed Mortadza SA, Lovatt M, Yang W. The TRPM2 channel nexus from oxidative damage to Alzheimer's pathologies: An emerging novel intervention target for age-related dementia. Ageing Res Rev 2018;47:67-79. [PMID: 30009973 DOI: 10.1016/j.arr.2018.07.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
23 Baszczyňski O, Watt JM, Rozewitz MD, Guse AH, Fliegert R, Potter BVL. Synthesis of Terminal Ribose Analogues of Adenosine 5'-Diphosphate Ribose as Probes for the Transient Receptor Potential Cation Channel TRPM2. J Org Chem 2019;84:6143-57. [PMID: 30978018 DOI: 10.1021/acs.joc.9b00338] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]